Vaxil Bio(TSE:VXL)
CA$0.110.00 (0.00%)
TSE:VXL
Vaxil Bio financials statements
CA$0.11
At close:0.00 (0.00%)
Want to see TSE:VXL full AI Analyst Report?
Vaxil Bio (VXL) Income Statement
22 Followers
Vaxil Bio Income Statement
Last quarter (Q2 2026), Vaxil Bio's total revenue was C$0.00. In Q2, Vaxil Bio's net income was C$-64.00K. See Vaxil Bio’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | |
| C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ -2.00K | C$ -25.00K | |
| C$ 179.00K | C$ 196.00K | C$ 254.00K | C$ 584.00K | C$ 986.00K | |
| Depreciation and Amortization | C$ 0.00 | C$ 148.00K | C$ 2.00K | C$ 2.00K | C$ 25.00K |
| C$ -179.00K | C$ -30.00K | C$ -252.00K | C$ -582.00K | C$ -961.00K | |
| C$ -179.00K | C$ -196.00K | C$ -254.00K | C$ -584.00K | C$ -986.00K | |
| C$ 700.00K | C$ 18.00K | C$ 0.00 | C$ 0.00 | C$ 0.00 | |
| C$ 521.00K | C$ -178.00K | C$ -254.00K | C$ -584.00K | C$ -986.00K | |
| C$ 522.00K | C$ -178.00K | C$ -254.00 | C$ -584.00K | C$ -986.00K | |
| Per Share Metrics | |||||
| Basic EPS | C$ 0.18 | C$ -0.00 | C$ -0.10 | C$ 0.00 | C$ -0.01 |
| Diluted EPS | C$ 0.18 | C$ -0.00 | C$ -0.10 | C$ 0.00 | C$ -0.01 |
| Weighted Average Shares Outstanding | 2.84M | 136.98M | 136.98M | 136.98M | 136.10M |
| Weighted Average Shares Outstanding (Diluted) | 2.84M | 136.98M | 136.98M | 136.98M | 136.10M |
Currency in CAD
